Matin RN, Dinnes J. AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation.
Br J Cancer 2021;
124:1749-1750. [PMID:
33742148 PMCID:
PMC8144419 DOI:
10.1038/s41416-021-01302-3]
[Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Revised: 01/26/2021] [Accepted: 02/03/2021] [Indexed: 11/08/2022] Open
Abstract
Smartphone applications ("apps") with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers' claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.
Collapse